主动脉腔内修复术中原位顺行激光开窗技术
报告激光开窗腔内移植术(LfEVAR)的技术与初步结果,用于不适合开放手术且无法使用定制器械的胸腹主动脉瘤、IA型内漏和肾旁主动脉瘤患者。2015年8月至2017年3月连续治疗16例患者,完成33个激光开窗,内脏动脉开窗成功率94.3%,平均随访17个月无死亡,随访CT显示97%一期通畅率。结论认为该技术可行且安全,尤其适用于急诊病例。
要点
- LfEVAR是一种医师改良技术,用于不适合开放手术且无法使用定制器械的高危患者。
- 16例患者中完成33个激光开窗,内脏动脉开窗成功率94.3%。
- 平均随访17个月无死亡,随访CT显示97%一期通畅率。
核心结论
- 原位顺行激光开窗腔内移植术(LfEVAR)可行且安全,可作为高危不可手术或无法使用定制器械腔内移植患者的选择,尤其适用于急诊病例。
研究设计与样本
- 报告LfEVAR技术与初步结果,患者为多学科团队评估不适合开放手术且无法受益于定制器械的胸腹主动脉瘤、IA型内漏和肾旁主动脉瘤患者。
- 2015年8月至2017年3月连续治疗16例患者,包括2例胸腹主动脉瘤、4例IA型内漏和10例肾旁主动脉瘤。
主要发现
- 共完成33个激光开窗,内脏动脉开窗成功率94.3%。
- 中位缺血时间:肠系膜上动脉7.5分钟,左肾动脉48分钟,右肾动脉50分钟,腹腔干125分钟。
- 需4例二次手术:2例内漏(II型和III型),2例与开窗相关(1例肾动脉支架移位,1例肾动脉支架狭窄)。
- 平均随访17个月无死亡;30天、6、12和18个月随访CT扫描结果满意,观察到4例内漏和2例动脉瘤增大。
- 随访CT影像显示97%一期通畅率。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The technique and preliminary outcomes are reported for laser fenestrated endografting (LfEVAR), developed as an alternative procedure for endovascular repair of thoraco-abdominal aortic aneurysms (TAAAs), type IA endoleaks (T1AELs), and pararenal aortic aneurysms (PAAAs). METHODS: Patients with TAAA, T1AEL, and PAAA considered unfit for open repair by a multidisciplinary team and who could not benefit from a custom made device were selected. LfEVAR is a physician modified technique requiring sequential steps. After preliminary stenting of each target artery, a standard stent graft was deployed in the aorta. Laser fenestration was performed using a steerable sheath positioned in the stent graft lumen in front of each target artery ostium. After progressive dilation of the laser fenestration, bridging stents were placed and flared to insure accurate perfusion of the visceral arteries. RESULTS: Between August 2015 and March 2017, 16 consecutive patients were treated using LfEVAR including two TAAAs, four T1AELs, and 10 PAAAs. Thirty-three laser fenestrations were performed with a 94.3% success rate for visceral artery fenestration. The median ischaemic was 7.5 minutes for the superior mesenteric artery, 48 and 50 minutes for the left and right renal arteries, and 125 minutes for the coeliac trunk. Four secondary procedures were required: two endoleaks (type II and III), and two related to fenestrations: one renal stent dislocation, and one renal artery stent stenosis. During a mean follow up of 17 months, no deaths occurred. Follow up computed tomography (CT) scans performed at 30 days, 6, 12, and 18 months were satisfactory (4 endoleaks and two aneurysm enlargements were observed). The follow up CT scan imaging demonstrated 97% primary patency. CONCLUSION: In situ antegrade LfEVAR is feasible and a safe alternative option for high risk inoperable patients or for those not eligible for custom made device endografting, particularly in emergency cases.
引用
- Le Houérou T, Fabre D, Alonso CG, et al. In Situ Antegrade Laser Fenestrations During Endovascular Aortic Repair. Eur J Vasc Endovasc Surg. 2018. PMID: 30196815. doi:10.1016/j.ejvs.2018.05.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。